NM_000540.3:c.6617C>T
Variant summary
The NM_000540.3(RYR1):c.6617C>T (p.Thr2206Met) variant causes a missense change involving the alteration of a conserved nucleotide. The gene RYR1 is a tumor suppressor gene (CancerMine: 1 TSG, 1 oncogene citations). The gene RYR1 is a known oncogene (CancerMine: 1 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.0000223 (AC=36) in the gnomAD database across 1,613,882 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000197. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.91). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV001434860: Multiple independent in vitro experiments showed this variant is functionally damaging (PMID 12220451, 19648156, 27586648)." and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.T2206R: not_provided (ClinVar VariationId 133164); p.T2206= (synonymous): Likely_benign (ClinVar VariationId 2144678, 2 stars) This exact variant is curated in the UniProt human variants database as Pathogenic, associated with Malignant hyperthermia, susceptibility to, 1 (mhs1).
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Publications
- malignant hyperthermia, susceptibility to, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
- RYR1-related myopathyInheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
- congenital multicore myopathy with external ophthalmoplegiaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- central core myopathyInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- King-Denborough syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant hyperthermia of anesthesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- benign Samaritan congenital myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital myopathy with myasthenic-like onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★★) | ||
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000020 — very rare (O3 supporting [+1]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 5 pathogenic, 0 benign (OR vs. background: 55.0); Variant does not impact splicing — splice-hotspot path not applicable |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
RYR1 | TSL:5MANE Select | c.6617C>T p.Thr2206Met | missense | Exon 40 of 106 | Prot: ENSP00000352608.2 UniProt: | |
RYR1 | TSL:1 | c.6617C>T p.Thr2206Met | missense | Exon 40 of 105 | Prot: ENSP00000347667.3 UniProt: | |
RYR1 | TSL:1 | n.6617C>T | non_coding_transcript_exon | Exon 40 of 103 | Prot: ENSP00000470927.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000394 | AC:6 | Hom:0 | AN:152168 | Cov:32 |
GnomAD2 exomes | AF: 0.0000199 | AC:5 | AN:251224 | ||
GnomAD4 exome | AF: 0.0000205 | AC:30 | Hom:0 | AN:1461714 | Cov:32 |
GnomAD4 genome | AF: 0.0000394 | AC:6 | Hom:0 | AN:152168 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000302 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000464 | AC:4 | Hom:0 | AN:86150 | |
Local & regional cohorts 2 sources | |||||
ChinaMAP Phase 1 | AF: 0.0000492 | ||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00000800 | AC:1 | Hom:0 | AN:122320 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000104 * | 1 | 9620 | 0.00 * | 0 | 10426 |
BipEx | 0.0000352 | 1 | 28420 | 0.0000347 | 1 | 28844 |
Epi25 | 0.00 | 0 | 41956 | 0.0000299 | 2 | 66886 |
SCHEMA | 0.0000412 | 4 | 97204 | 0.0000191 | 3 | 156662 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.75 | |
BayesDel_addAF | Pathogenic | 0.46 | D |
BayesDel_noAF | Pathogenic | 0.49 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.94 | D |
Eigen | Pathogenic | 0.71 | |
Eigen_PC | Uncertain | 0.66 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
GPN-Star LLR | N/A | -8.6 | |
GPN-Star score | N/A | 8.6 | |
LIST_S2 | Pathogenic | 1.0 | D |
M_CAP | Pathogenic | 0.66 | D |
MetaRNN | Pathogenic | 0.95 | D |
MetaSVM | Pathogenic | 1.0 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Uncertain | 2.5 | M |
PhyloP100 | Pathogenic | 7.9 | |
PrimateAI | Pathogenic | 0.90 | D |
PROVEAN | Pathogenic | -5.2 | D |
REVEL | Pathogenic | 0.95 | |
Sift | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.72 | |
VESM-3B | Benign | -9.4 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.